however, individuals already taking glucose-lowering medicines (including insulin) may be at increased risk of hypoglycaemia if GH-mediated effects alter their insulin sensitivity Injection site reactions, including pain, redness, and infection risk For retatrutide , the side effect profile observed in clinical trials is consistent with that of other GLP-1 receptor agonists and includes nausea, vomiting, diarrhoea, and constipation
Peptides 2018;100:4853.ArticlePubMed 108
The bone loss is likely from rapid weight loss, not the drug itself
Amino acids can support muscle protein synthesis, but resistance training remains the primary stimulus for preserving and building muscle
Published pathway literature can supply background for controlled laboratory research, but it should not be converted into claims about a product
Xiong, L., Lee, H., Ishitani, M